The world barbituric acid market is expected to reach around US$ 19.8 Million by 2022.  Furthermore, with increasing adoption of barbituric acid in industries like pharmaceutical, plastic, polymer, textile, etc., the total demand for barbituric acid is likely to grow at a constant CAGR of 4.6 % between 2022 and 2032 for a total of over US$ 31.04 Million by 2032.

Barbituric acid is predominantly used for the production of barbiturate drugs. Barbituric acid is an organic compound characterized by a six-membered ring structure and belongs to the class of the pyrimidine family. One of the barbiturate drugs produced using barbituric acid is riboflavin which is used as a vitamin B2 nutritional supplement.

Barbiturate drugs have a sedative effect on the central nervous system and are being prescribed for anxiety. These drugs act as central nervous system depressants and are used for the treatment of insomnia, and epilepsy amongst others. Apart from its use as a pharmaceutical intermediate, barbituric acid is also used as a dye intermediate and as a nutritional supplement.

Global Barbituric Acid Market Participants

Some of the market participants identified across the value chain of the global Barbituric Acid market are:

• Hebei Chengxin Co., Ltd.
• Ralington Pharma
• Explicit chmicals pvt. ltd.
• Zhengzhou Lifeng Chemical Co.,Ltd.
• Danopharm Chemicals Pvt. Ltd.
• CDH Druh House (P) Ltd.
• Hunan HongQiang Chem Technology Development Co., Ltd.
• Sparchem
• Hem Corporation
• GFS Chemicals Inc

For Details on Vendors and their Offerings – Request a Sample Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-8611

Key Segments Profiled in the Barbituric Acid Industry Survey

By Grade:

• Regular grade 98% (Industrial Grade)
• High Purity Grade 99% (Pharmaceutical Grade)

By Application:

• Pharmaceutical intermediate
• Dye intermediate
• Nutritional supplement

By End-Use Industry:

• Plastics
• Textiles
• Polymers
• Pharmaceutical
• Others

Global Barbituric Acid Market: Regional Outlook

In terms of regional perspective, the global barbituric acid market is anticipated to be dominated by the Asia Pacific region. China is anticipated to hold a noteworthy share of the global barbituric acid market both in terms of production as well as consumption.

Regions such as North America and Europe are anticipated to witness a rise in demand for barbituric acid owing to the increase in the number of patients suffering from sleeping disorders and other diseases which are treated using barbiturate drugs. Japan, the Middle East and Africa, and Latin America are anticipated to hold a relatively smaller share in volumes but are projected to witness robust growth in the forthcoming years.